본문 바로가기
KERD
논문KCI 등재

Epstein-Barr Virus and Gastric Cancer Risk: A Meta- analysis With Meta-regression of Case-control Studies

배종면|김은희
대한예방의학회 (The Korean Society For Preventive Medicine)|2016.03|예방의학회지 (Journal of Preventive Medicine and Public Health)|제49권 제2호|pp. 97-107

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

Risk factorMeta-analysisEpstein-Barr virusGastric neoplasms
주제분류예방의학/직업환경의학

초록

Objectives: Research on how the risk of gastric cancer increases with Epstein-Barr virus (EBV) infection is lacking. In a systematic review that investigated studies published until September 2014, the authors did not calculate the summary odds ratio (SOR) due to heterogeneity across studies. Therefore, we include here additional studies published until October 2015 and conduct a meta-analysis with meta-regression that controls for the heterogeneity among studies. Methods: Using the studies selected in the previously published systematic review, we formulated lists of references, cited articles, and related articles provided by PubMed. From the lists, only case-control studies that detected EBV in tissue samples were selected. In order to control for the heterogeneity among studies, subgroup analysis and meta-regression were performed. Results: In the 33 case-control results with adjacent non-cancer tissue, the total number of test samples in the case and control groups was 5280 and 4962, respectively. In the 14 case-control results with normal tissue, the total number of test samples in case and control groups was 1393 and 945, respectively. Upon meta-regression, the type of control tissue was found to be a statistically significant variable with regard to heterogeneity. When the control tissue was normal tissue of healthy individuals, the SOR was 3.41 (95% CI, 1.78 to 6.51; I-squared, 65.5%). Conclusions: The results of the present study support the argument that EBV infection increases the risk of gastric cancer. In the future, age-matched and sex-matched case-control studies should be conducted.

Abstract

Objectives: Research on how the risk of gastric cancer increases with Epstein-Barr virus (EBV) infection is lacking. In a systematic review that investigated studies published until September 2014, the authors did not calculate the summary odds ratio (SOR) due to heterogeneity across studies. Therefore, we include here additional studies published until October 2015 and conduct a meta-analysis with meta-regression that controls for the heterogeneity among studies. Methods: Using the studies selected in the previously published systematic review, we formulated lists of references, cited articles, and related articles provided by PubMed. From the lists, only case-control studies that detected EBV in tissue samples were selected. In order to control for the heterogeneity among studies, subgroup analysis and meta-regression were performed. Results: In the 33 case-control results with adjacent non-cancer tissue, the total number of test samples in the case and control groups was 5280 and 4962, respectively. In the 14 case-control results with normal tissue, the total number of test samples in case and control groups was 1393 and 945, respectively. Upon meta-regression, the type of control tissue was found to be a statistically significant variable with regard to heterogeneity. When the control tissue was normal tissue of healthy individuals, the SOR was 3.41 (95% CI, 1.78 to 6.51; I-squared, 65.5%). Conclusions: The results of the present study support the argument that EBV infection increases the risk of gastric cancer. In the future, age-matched and sex-matched case-control studies should be conducted.

참고문헌 (77)

  1. Ferlay J, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008", Int J Cancer, 127(12), pp.2893~2917 (2010)
  2. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
  3. Murphy G, "Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location", Gastroenterology, 137(3), pp.824~833 (2009)
  4. Shi J, "Pathogenetic mechanisms in gastric cancer", World J Gastroenterol, 20(38), pp.13804~13819 (2014)
  5. Wroblewski LE, "Helicobacter pylori in gastric carcinogenesis:mechanisms", Gastroenterol Clin North Am, 42(2), pp.285~298 (2013)
  6. Shinozaki-Ushiku A, "Update on Epstein-Barr virus and gastric cancer (review)", Int J Oncol, 46(4), pp.1421~1434 (2015)
  7. Chen XZ, "Epstein-Barr virus infection and gastric cancer: a systematic review", Medicine (Baltimore), 94(20), pp.e792~ (2015)
  8. Javier RT, "The history of tumor virology", Cancer Res, 68(19), pp.7693~7706 (2008)
  9. Camargo MC, "Determinants of Epstein-Barr viruspositive gastric cancer: an international pooled analysis", Br J Cancer, 105(1), pp.38~43 (2011)
  10. "Agents classified by the IARC monographs, volumes 1–112"[URL]
  11. Burke AP, "Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction", Mod Pathol, 3(3), pp.377~380 (1990)
  12. Akiba S, "Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features", Cancer Sci, 99(2), pp.195~201 (2008)
  13. Cancer Genome Atlas Research Network, "Comprehensive molecular characterization of gastric adenocarcinoma", Nature, 513(7517), pp.202~209 (2014)
  14. Fukayama M, "Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma", Cancer Sci, 99(9), pp.1726~1733 (2008)
  15. Uozaki H, "Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms", Int J Clin Exp Pathol, 1(3), pp.198~216 (2008)
  16. Li S, "Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma", Sci China Life Sci, 53(4), pp.524~530 (2010)
  17. Sousa H, "Epstein-Barr virus is associated with gastric carcinoma: the question is what is the significance", World J Gastroenterol, 14(27), pp.4347~4351 (2008)
  18. Lee JH, "Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis", J Gastroenterol Hepatol, 24(3), pp.354~365 (2009)
  19. Zong L, "CpG island methylator phenotype, Helicobacter pylori, Epstein-Barr virus, and microsatellite instability and prognosis in gastric cancer: a systematic review and meta-analysis", PLoS One, 9(1), pp.e86097~ (2014)
  20. Chen YP, "Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based metaanalysis", Oncotarget, 6(30), pp.29311~29323 (2015)
  21. Liu X, "Prognostic significance of Epstein-Barr virus infection in gastric cancer: a metaanalysis", BMC Cancer, 15, pp.782~ (2015)
  22. Liang W, "Hypothetic association between human papillomavirus infection and breast carcinoma", Med Hypotheses, 70(2), pp.305~307 (2008)
  23. Sterne JA, "Funnel plots in meta-analysis", Stata J, 4(2), pp.127~141 (2004)
  24. Harbord RM, "Meta-regression in Stata", Stata J, 8(4), pp.493~519 (2008)
  25. Harbord RM, "A modified test for smallstudy effects in meta-analyses of controlled trials with binary endpoints", Stat Med, 25(20), pp.3443~3457 (2006)
  26. Bae JM, "Narrative reviews", Epidemiol Health, 36, pp.e2014018~ (2014)
  27. Bae JM, "Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis", Epidemiol Health, 37, pp.e2015005~ (2015)
  28. 배종면, "Hormone Replacement Therapy and Risk of Breast Cancer in Korean Women: A Quantitative Systematic Review", 예방의학회지, 48(5), pp.225~230 (2015), 대한예방의학회
  29. Sakuma K, "Cancer risk to the gastric corpus in Japanese, its correlation with interleukin-1beta gene polymorphism (+3953*T) and Epstein-Barr virus infection", Int J Cancer, 115(1), pp.93~97 (2005)
  30. Yuan XY, "Non-detection of Epstein-Barr virus and Human Papillomavirus in a region of high gastric cancer risk indicates a lack of a role for these viruses in gastric carcinomas", Genet Mol Biol, 36(2), pp.183~184 (2013)
  31. Koshiol J, "Epstein-Barr virus serology and gastric cancer incidence and survival", Br J Cancer, 97(11), pp.1567~1569 (2007)
  32. Kim Y, "Epstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control study", Br J Cancer, 101(3), pp.526~529 (2009)
  33. Schetter AJ, "Association of Epstein-Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort", Cancer Sci, 99(2), pp.350~354 (2008)
  34. Tokunaga M, "Epstein-Barr virus in gastric carcinoma", Am J Pathol, 143(5), pp.1250~1254 (1993)
  35. Gurtsevich VE, "Detection and characterization of gastric carcinoma associated with Epstein-Barr herpes virus", Vestn Ross Akad Med Nauk, (3), pp.56~59 (1999)
  36. Yanai H, "Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma", Gastrointest Endosc, 45(3), pp.236~342 (1997)
  37. Luo B, "Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas", World J Gastroenterol, 11(5), pp.629~633 (2005)
  38. Shukla SK, "Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases", Braz J Infect Dis, 15(6), pp.583~590 (2011)
  39. Shukla SK, "Expression profile of latent and lytic transcripts of epstein-barr virus in patients with gastroduodenal diseases: a study from northern India", J Med Virol, 84(8), pp.1289~1297 (2012)
  40. Imai S, "Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein", Proc Natl Acad Sci U S A, 91(19), pp.9131~9135 (1994)
  41. Galetsky SA, "Epstein-Barr-virus-associated gastric cancer in Russia", Int J Cancer, 73(6), pp.786~789 (1997)
  42. Ishii HH, "Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas", J Clin Pathol, 57(12), pp.1306~1311 (2004)
  43. Wang Y, "Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma", Ai Zheng, 23(7), pp.782~787 (2004)
  44. Saxena A, "Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease", Scand J Gastroenterol, 43(6), pp.669~674 (2008)
  45. Shibata D, "Epstein-Barr virus-associated gastric adenocarcinoma", Am J Pathol, 140(4), pp.769~774 (1992)
  46. Shibata D, "Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii", Cancer Epidemiol Biomarkers Prev, 2(3), pp.213~217 (1993)
  47. Fukayama M, "Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach", Lab Invest, 71(1), pp.73~81 (1994)
  48. Ott G, "Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma", Histopathology, 25(4), pp.323~329 (1994)
  49. Shousha S, "Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa", J Clin Pathol, 47(8), pp.695~698 (1994)
  50. Yuen ST, "In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas", Am J Surg Pathol, 18(11), pp.1158~1163 (1994)
  51. Anwar K, "Infection of human papillomavirus (hpv) and Epstein-Barr-virus (EBV) and p53overexpression in human gastric-carcinoma", Int J Oncol, 7(2), pp.391~397 (1995)
  52. Harn HJ, "Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan", Hum Pathol, 26(3), pp.267~271 (1995)
  53. Gulley ML, "Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation", Hum Pathol, 27(1), pp.20~27 (1996)
  54. Moritani S, "Phenotypic characteristics of Epstein-Barr-virus-associated gastric carcinomas", J Cancer Res Clin Oncol, 122(12), pp.750~756 (1996)
  55. Simon G, "Variation in drug prescription costs and general practitioners in an area of North-East Italy. The use of current data", Epidemiol Prev, 18(61), pp.224~229 (1994)
  56. Shin WS, "Epstein-Barr virus-associated gastric adenocarcinomas among Koreans", Am J Clin Pathol, 105(2), pp.174~181 (1996)
  57. Durmaz R, "Investigation of the relationship between Epstein-Barr virus and ordinary gastric carcinoma using the nested polymerase chain reaction", Acta Virol, 42(6), pp.359~363 (1998)
  58. Hsieh LL, "Frequency of Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan", Cancer Lett, 129(2), pp.125~129 (1998)
  59. Kume T, "Low rate of apoptosis and overexpression of bcl-2 in Epstein-Barr virus-associated gastric carcinoma", Histopathology, 34(6), pp.502~509 (1999)
  60. Wan R, "In situ detection of Epstein Barr virus in gastric carcinoma tissue in China highrisk area", World J Gastroenterol, 5(6), pp.531~532 (1999)
  61. Chapel F, "Epstein-Barr virus and gastric carcinoma in Western patients:comparison of pathological parameters and p53 expression in EBV-positive and negative tumours", Histopathology, 36(3), pp.252~261 (2000)
  62. Corvalan A, "Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile", Int J Cancer, 94(4), pp.527~530 (2001)
  63. Lo YM, "Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma", Clin Cancer Res, 7(7), pp.1856~1859 (2001)
  64. Luqmani YA, "Detection of Epstein-Barr virus in gastrectomy specimens", Oncol Rep, 8(5), pp.995~999 (2001)
  65. Kang GH, "Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma", Am J Pathol, 160(3), pp.787~794 (2002)
  66. Oda K, "Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes", Gastric Cancer, 6(3), pp.173~178 (2003)
  67. Lee MA, "Detection of Epstein-Barr virus by PCR and expression of LMP1, p53, CD44 in gastric cancer", Korean J Intern Med, 19(1), pp.43~47 (2004)
  68. Lopes LF, "Epstein-Barr virus infection and gastric carcinoma in São Paulo State", Brazil. Braz J Med Biol Res, 37(11), pp.1707~1712 (2004)
  69. Alipov G, "Epstein-Barr virus-associated gastric carcinoma in Kazakhstan", World J Gastroenterol, 11(1), pp.27~30 (2005)
  70. Herrera-Goepfert R, "Epstein-Barr virus-associated gastric carcinoma: evidence of age-dependence among a Mexican population", World J Gastroenterol, 11(39), pp.6096~6103 (2005)
  71. von Rahden BH, "No association of primary adenocarcinomas of the small bowel with Epstein-Barr virus infection", Mol Carcinog, 45(5), pp.349~352 (2006)
  72. Truong CD, "Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A", J Exp Clin Cancer Res, 28, pp.14~ (2009)
  73. Chen JN, "Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China", J Med Virol, 82(4), pp.658~667 (2010)
  74. de Aquino PF, "Epstein-Barr virus DNA associated with gastric adenocarcinoma and adjacent non-cancerous mucosa in patients from Manaus", Brazil. Genet Mol Res, 11(4), pp.4442~4446 (2012)
  75. Zhao J, "Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer", Cancer, 118(4), pp.924~936 (2012)
  76. de Souza CR, "Occurrence of Helicobacter pylori and Epstein-Barr virus infection in endoscopic and gastric cancer patients from Northern Brazil", BMC Gastroenterol, 14, pp.179~ (2014)
  77. Weinstein SJ, "Dietary factors of one-carbon metabolism and prostate cancer risk", Am J Clin Nutr, 84(4), pp.929~935 (2006)

관련 논문AI추천

Clinical Significance of Epstein-Barr Virus and Helicobacter pylori Infection in Gastric Carcinoma김도훈, 박영수, 송호준, 안지용, 이인섭, 이진혁, 최기돈, Jung Hwoon-Yong, Jung Kee Wook, Kim Ga Hee, Lee Jeong Hoon, Na Hee Kyong, Noh Jin Hee, Shin Jun Young거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제1호Epstein-Barr Virus in Human Malignancy: A Special Reference to Epstein-Barr Virus Associated Gastric Carcinoma김우호, Mee Soo Chung대한암학회 · Cancer Research and Treatment2005 · 제37권 제5호Helicobacter pylori Infection and Risk of Gastric Cancer in Korea: A Quantitative Systematic Review김은희, 배종면대한예방의학회 · 예방의학회지2016 · 제49권 제4호Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea국명철, 김영우, 남병호, 성문우, 조수정, 최일주, Chan Gyoo Kim, Jong Seok Lee, Jong Yeul Lee, Jun Ho Lee, Keun Won Ryu, Sook Ryun Park, Young-Iee Park거트앤리버 소화기연관학회협의회 · Gut and Liver2010 · 제4권 제4호Clinical Relevance of Helicobacter pylori Coinfection in Ebstein-Barr Virus-Associated Gastric CarcinomaLee Bong Eun거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제1호위암에서 Epstein-Barr Virus 연관성의 예측 인자김영수, 남상철, 박선균, 배한익, 서인수, 정지윤, 한만훈대한병리학회 · Journal of Pathology and Translational Medicine2008 · 제42권 제4호

이 간행물의 다른 논문 (8건)

Our Valuable Contributors: Reviewers of 2015조성일pp. 79-79Proving Causation With Epidemiological Evidence in Tobacco Lawsuits이선구pp. 80-96The Association Between Smoking Tobacco After a Diagnosis of Diabetes and the Prevalence of Diabetic Nephropathy in the Korean Male Population김현창, 서일, 이정현, 염형선pp. 108-117Enrollment in Private Medical Insurance and Utilization of Medical Services Among Children and Adolescents: Data From the 2009-2012 Korea Health Panel Surveys감신, 두영택, 류동희pp. 118-128Citation Discovery Tools for Conducting Adaptive Meta-analyses to Update Systematic Reviews배종면, 김은희pp. 129-133
원문 보기